Abstract We reviewed the current use of spacers in the management of the infected knee prosthesis. There are two types of temporary spacers: block or non-articulating spacers and articulating or mobile spacers. Generally, spacers improve mobilisation and hasten recovery with shorter hospital stay between stages. Furthermore, spacers facilitate the second-stage procedure by maintaining joint space, and articulating spacers may also maintain range of motion. Last but not the least, the cost of spacers represents only a small fraction of the total expenses for management of infected knee arthroplasties.
Introduction
The infection rate after primary total knee arthroplasty (TKA) ranges from 0.5 to 2% [1, 31] and is a serious problem despite modern technology and rigourous prophylaxis. Peersman et al. [27] reported recently a 0.43% rate of deep infection in a consecutive series of 6,439 total knee arthroplasties performed with vertical laminar airflow and body exhaust suits. This is encouraging; however, considering the increasing number of patients with TKA, infection is still a complication of major concern [3, 2, 28, 29, 30, 35, 37] .
A variety of techniques and devices have been developed to improve the management of the infected TKA. Antibiotic-loaded bone cement spacers in the twostage re-implantation technique allow early joint and patient mobilisation, a shorter hospital stay and potentially a reduced rate of re-infection. In this article, we have reviewed the use of joint spacers and outlined their potential benefits and drawbacks.
The infected TKA
The choice of management for patients with infected TKA depends on many factors; nevertheless, the clinical presentation of infection can be used as a guide to the treatment. Segawa et al. [33] proposed a classification based on the clinical presentation, focusing on the severity of symptoms and the temporal relationship between the index operation and the infection. The classification recognises four types of infections: (1) early postoperative infection, (2) late chronic infections, (3) acute haematogenous infections, and (4) sub-clinical infections with positive cultures.
The early post-operative infection (type 1) is defined as a wound infection (superficial or deep) developing less than 4 weeks after the index operation. The treatment for superficial infection is extra-articular soft-tissue debridement and a course of antibiotics [25] . Deep infection extends into the joint and requires aggressive treatment including debridement, exchange of the tibial polyethylene insert and intravenous administration of antibiotics. Intra-articular placement of antibiotic-loaded cement beads has also been advocated [26] . Retention of prosthesis is possible in early post-operative deep infection if the implant appears well fixed.
Late chronic infections (type 2) develop 4 weeks or more after the index operation and have an insidious clinical presentation. These infections are most commonly treated with debridement, implant removal and placement of antibiotic-impregnated cement spacer or antibiotic-impregnated cement beads. This is followed by a course of systemic antibiotics for 6 weeks and a delayedexchange arthroplasty (two-stage reimplantation technique).
The acute haematogenous infection (type 3) is associated with a documented or suspected antecedent bacteraemia and is characterised by an acute onset of severe pain and swelling. These infections are treated with debridement, exchange of the polyethylene insert of the tibial component, retention of prosthesis if it is well fixed and intravenous antibiotics for 6 weeks. The non-specific symptoms and signs of a sub-clinical infection (type 4) generally lead to the patient proceeding to revision surgery for presumed aseptic loosening. The patient is then treated with intravenous antibiotics for 6 weeks, often without requiring repeated revision surgery, essentially because of the wide antibiotic susceptibility of the infecting organisms.
Two-stage revision
It is widely accepted that the most reliable outcome for the treatment of late chronic infection is obtained by a two-stage technique involving implant removal followed by a 6-week course of systemic antibiotics and delayed exchange arthroplasty. The success rate has been reported at around 90% [14, 22, 32, 36, 37] . The two-stage reimplantation has become a procedure of choice to eradicate the infection and maintain a functional extremity.
The major disadvantage of this method is the period between stages, which is often associated with pain, difficult mobility and knee instability [13, 18] . Furthermore, reimplantation is often difficult because of scar formation, shortening of the extensor mechanism, and retraction of the joint capsule and ligaments. To overcome these difficulties, temporary joint spacers have been introduced [16, 24] .
Spacers
Spacers have been reported successful in preserving limb length and minimising soft-tissue contracture, therefore facilitating re-implantation [7, 15, 38] . Furthermore, the insertion of an antibiotic-loaded cement spacer, in addition to the elution of high levels of antibiotic into the joint, allow ambulation, rehabilitation and earlier discharge from the hospital between stages [11] . Essentially, there are two types of temporary spacers: (1) block spacers (also known as non-articulating or static spacers), and (2) articulating spacers (also known as mobile spacers).
Block spacers
The use of block spacers was first reported in 1988 by Cohen et al. [7] and Wilde and Ruth [36] . Antibioticimpregnated polymethylmethacrylate cement blocks are handmade in the operating room and fashioned to fit the bone stock defect left after removal of the infected prosthesis. A small cement stem can be added to the spacer block to achieve adequate fixation. The impregnated cement allows higher local concentrations of antibiotics, and the block itself maintains the articulating space and prevents retraction of the collateral ligaments. These factors facilitate easier re-implantation. Static knee spacers are a better option for knees with severe bone loss, as the mobile spacers cannot maintain stability in these settings [4, 5, 10, 12, 17] .
Block spacers present several disadvantages: patients are not allowed to move the knee, they require cast immobilisation between stages and the spacer can dislodge and cause bone erosion. Moreover, second-stage surgery is still difficult due to scar formation, tissue adherence and quadriceps shortening.
Articulating knee spacers
To overcome the disadvantages of block spacers and to ease reimplantation surgery further, several authors have independently introduced articulated spacers [20, 21] . Emerson et al. [10] compared static block spacers (26 knees) with articulating spacers (22 knees) and found an improved post-operative range of motion in the articulating spacer group (108 compared with 94) with no significant difference in the reinfection rate at 36 months (9% compared with 7.6%).
Essentially, there are three types of articulating spacers: (1) temporary prosthesis from re-sterilised components or new components (also called spacer prosthesis), (2) cement spacers moulded during operation, and (3) preformed cement spacers.
Temporary prosthesis
Scott et al. [32] described a modified technique cementing the original prosthesis between stages after re-sterilisation in autoclave. The cement was loaded with antibiotics. Additionally, antibiotic-loaded cement beads were inserted into the medullary canal of the tibia and femur and into the joint space. At 6 weeks, the final stage was performed fixing the definitive prosthesis using antibiotic-loaded bone cement according to the sensitivity profile of the infecting organism. In 1995, Hoffmann et al. [21] described a similar technique with articulating spacers, this time using the removed and sterilised femoral and tibial components, a new polyethylene tibial insert and a new all-polyethylene patellar component without pegs. The spacer was fixed using antibiotic-impregnated bone cement mixed in a ratio of 4.8 g of tobramycin to 40 g of cement. Cement was applied to the bone at the end of the working phase to mould the surfaces without deep interdigitation. Partial weight bearing and range-of-motion exercises were allowed after surgery. There was no recurrence of infection in this series of 25 patients at an average follow-up of 30 months.
Emerson et al. [10] suggested the use of 3.6 g of tobramycin and 2 g of vancomycin per 40 g of cement.
Haddad et al. [16] confirmed that the normal limit of antibiotic comprising 5% of the whole cement mass does not necessarily apply in temporary spacers. This does not seem to affect the mechanical properties of such constructs. Their major drawback is the presence of metallic and plastic prosthetic components between the revision stages that can, in theory, favour bacterial adhesion [14] . In many countries, current infectious-disease-control policies prohibit the use of removed and re-sterilised prosthetic implants. Moreover, the use of a new prosthesis as a spacer is an additional factor increasing the high costs of management of patients with infected TKA [19] .
Cement spacers moulded during operation
McPherson et al. [24] presented the technique of using a handmade mould of a TKA made of antibiotic-loaded cement as a temporary spacer in two-stage revision. Although this allowed some knee function, stability was difficult to maintain.
Duncan et al. [8, 9] also introduced an intra-operatively moulded cement spacer. This spacer had smooth articular surfaces obtained with the utilisation of plastic moulds. The spacer is a facsimile of a TKA prosthesis made entirely of antibiotic-loaded bone cement [Prostalac (prosthesis of antibiotic-loaded acrylic cement), Smith & Nephew, USA]. Haddad et al. [15] reported the use of the Prostalac spacer in two-stage revision for infected TKA in 45 consecutive patients. The mean follow-up was 48 months. At the final review, there was no evidence of infection in 41 patients (91%); only one had a recurrent infection, with the same organism. There was improvement in the Hospital for Special Surgery knee score, and the range of movement was maintained between stages. According to the authors, complications were primarily related to the extensor mechanism, wear and stability of the knee between stages. These problems have been addressed with refinement of the design. The new generation of Prostalac has femoral and tibial components made of antibiotic-loaded bone cement with a small metal-on-polyethylene articular surface and a posterior stabilised design. Generally, patients with these spacers in situ are allowed to walk with partial weight bearing, and free knee motion is encouraged with or without a brace.
One of the advantages of the Prostalac system is the ability to add a relatively large amount of antibiotic powder to the bone cement [23] . Again, the presence of metal and plastic, although in small amounts, could in theory favour bacterial adhesion. An objection can also be made that such "custom made" cement spacers cannot warrant reproducible mechanical properties.
Preformed cement spacers
Castelli et al. [6] recently introduced a preformed articulating spacer. The spacers are manufactured with ultra-congruent condylar knee prosthesis design made exclusively of acrylic cement impregnated with gentamicin antibiotic (Spacer-K, Tecres, Italy), and no additional reinforcement device is used. Both femoral and tibial components are produced in three sizes. Experimental studies have demonstrated good mechanical properties and standardised antibiotic release of this spacer. In theory, good mechanical properties without the presence of metal or plastic are an advantage in the treatment of infected TKA. Like other articulating spacers, Spacer-K is Fig. 1 A Post-operative anteroposterior and B lateral radiographs of a 75-year-old woman with total knee arthroplasty (TKA) late infection show a cemented antibiotic-loaded articulating spacer in satisfactory position fixed to the bone with cement loaded with antibiotics of the surgeon's choice. It allows partial weight bearing and knee motion exercises between stages (Fig. 1, 2 and 3) .
A prospective multi-centre study on Spacer-K [34] showed no recurrence of infection at a minimum followup of 6 months. Pre-operative range of motion remained unchanged between stages and improved after reimplantation. Neither breakage nor clinically relevant spacer wear were detected, and no complications related to the spacer were observed.
Conclusion
Infected TKA is a devastating complication, both for patient and surgeon. It causes major morbidity, and presents a difficult surgical management issue with possible unsatisfactory outcome, prolonged hospitalisation, and a period of marked limitation of mobility. Hebert et al. [19] reported that the surgical treatment of an infected TKA is three-to-four times as expensive as a primary procedure. Most of the cost was related to hospitalisation and antibiotic treatment.
Knee spacers used in the two-stage surgical management of infected TKA, at present the gold standard of treatment [11, 16, 20] , can improve mobilisation and hasten recovery, with shorter hospital stay between stages. Furthermore, in addition to the local delivery of high levels of antibiotics, spacers facilitate the secondstage procedure by maintaining the joint space and, in cases of articulating devices, maintain knee range of motion. It has been shown that patients with articulating spacers, when compared with block spacers, have better mobility after re-implantation, with similar complication and infection rates in the long term [11, 20, 23] . Last but not the least, the cost of spacers represents a relatively small fraction of the total expenses for the management of the infected TKA. Fig. 2 The articulating spacer allows range-of-motion exercises between stages. The patient is mobilised with crutches and partial weight bearing 
